Vanguard Capital Management Establishes 7.49% Passive Stake in Hologic Inc (HOLX)

2026-04-30SEC Filing SCHEDULE 13G (0002100119-26-000604)

Vanguard Capital Management LLC filed a Schedule 13G on April 30, 2026, reporting a new 7.49% stake in Hologic Inc (HOLX). As of the event date on March 31, 2026, the investment adviser beneficially owns 16,721,923 shares of Hologic's common stock. According to the filing, Vanguard Capital Management exercises sole dispositive power over all 16,721,923 shares, while holding sole voting power over 2,218,009 shares. The filing indicates that these securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The reporting entity includes various affiliates such as Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. This position represents a significant increase from a previously reported 0% ownership, establishing Vanguard as a major institutional shareholder in the medical technology company. Hologic is headquartered in Marlborough, Massachusetts, and specializes in women's health.